Ładuje się......
Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
In diffuse large B-cell lymphoma (DLBCL), predictive modeling may contribute to targeted drug development by enrichment of the study populations enrolled in clinical trials of DLBCL investigational drugs to include patients with lower likelihood of responding to standard of care. In clinical practic...
Zapisane w:
| Wydane w: | Cancer Inform |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publications
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421613/ https://ncbi.nlm.nih.gov/pubmed/30906191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1176935119835538 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|